BGC
NEO icon

Beutel, Goodman & Co’s NeoGenomics NEO Stock Holding History

Beutel, Goodman & Co’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
50
– – ﹤0.01% 176
2025
Q4 		$0 Hold
50
– – ﹤0.01% 175
2025
Q3 		$0 Hold
50
– – ﹤0.01% 179
2025
Q2 		$0 Hold
50
– – ﹤0.01% 193
2025
Q1 		$0 Buy
+50
New +$624 ﹤0.01% 206

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Beutel, Goodman & Co's NEO Position: Q1 2026 in Review

Beutel, Goodman & Co held its NeoGenomics (NEO) position steady in Q1 2026 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #176.

Beutel, Goodman & Co first reported a position in NEO in Q1 2025 and has held it in 5 quarters since. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Beutel, Goodman & Co held 50 shares of NeoGenomics worth $0 as of Q1 2026.
  • Beutel, Goodman & Co left its NeoGenomics share count unchanged in Q1 2026.
  • NeoGenomics made up ﹤0.01% of Beutel, Goodman & Co's portfolio in Q1 2026, its #176 holding.
  • Beutel, Goodman & Co first reported a position in NeoGenomics in Q1 2025 and has held it in 5 quarters since.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Beutel, Goodman & Co's 13F filing for Q1 2026, filed 15 May 2026.